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Expanding and contracting
This month’s issue features a dichotomy between 
the globally spreading and the globally disappearing. 
Migration and ageing lie behind the spreading disorders 
featured; vaccination and other prevention methods 
behind the decline of the others.
Frédéric Piel and colleagues’ fascinating Article explores 
the eﬀ ects of international migration since 1960 on the 
spread of the recessive gene (HbS) that causes sickle-cell 
anaemia. Before the transatlantic slave trade saw millions 
of African people forcibly relocated to the Americas, 
the textbook epidemiology of the HbS gene spoke of 
a disorder limited to malarious regions by virtue of the 
protective eﬀ ect of HbS carrier status against malaria. 
Large-scale voluntary migration during the second half 
of the 20th century has seen a third shift—and one to 
which public health professionals everywhere must face 
up. Piel and colleagues coupled data from the World Bank 
Global Bilateral Migration Database with their previously 
published estimates of national HbS frequencies to show 
that, between 1960 and 2000, the number of migrants 
with the HbS gene increased more rapidly than did the 
overall number of migrants, and the mean number 
of countries from which such individuals migrated to 
any one destination increased by 40%. Strikingly, the 
countries with the highest positive index of change (ie, 
the highest increase in HbS migration compared with 
overall migration) were Ecuador, Botswana, Portugal, and 
Thailand—ie, countries on four diﬀ erent continents.
The ﬁ ndings add to the establishment of sickle-cell 
disease as “a major global public health problem”, 
according to Graham Serjeant in his accompanying 
Comment. Some countries with existing screening, 
education, and management programmes will need to 
scale up their eﬀ orts, and others with no services will need 
to implement them. Although no longer usually a fatal 
neonatal condition, sickle-cell disease still has profound 
consequences for patients in terms of quality of life, 
productivity, and health-care expense, and more global 
recognition of the disorder from governments, health-
care professionals, and the general public would improve 
patients’ life chances in all respects.
Global recognition and concerted global action have 
brought the geographical extent of other diseases down 
to a few limited foci. Polio is the prime example, with just 
three countries—Afghanistan, Pakistan, and Nigeria—
being endemic for the disease. India celebrated its third 
year of being polio-free on Jan 13. But eliminating the 
disease from these remaining outposts has been scuppered 
in recent years by what Richard Horton recently referred to 
as social chaos: “the disruption, disorder, disorganisation, 
and decay of civil society and its institutions”. Social chaos 
has disrupted vaccination programmes in all three polio-
endemic countries and threatens to return others—eg, 
Syria—to the bad old days. In the second Article in this 
month’s issue, Tara Mangal and colleagues attempt to 
drill down into the speciﬁ cs of what perpetuates polio 
transmission in Nigeria—the country that accounted for 
more than 50% of cases worldwide in 2012. The ﬁ ndings 
reveal a complex mix of factors: poor vaccine eﬃ  cacy in the 
north of the country; low vaccine coverage and population 
immunity in high-risk areas; and continued refusals and 
lack of awareness of the availability and importance of 
vaccination. In their accompanying Comment, Festus Adu 
and Itam Hogan Itam point to other potential inﬂ uences 
such as political inﬁ ghting, cultural perceptions of having 
a disabled child, and maternal education. The situation 
in Nigeria has improved somewhat since 2012 after new 
strategies were put in place to address some of these 
factors, and hopes are high that Nigeria can recover from 
the hiccup of 2011/12 and move towards elimination.
Eradication of another infectious scourge—malaria—is 
a goal not universally agreed upon. In our maiden issue 
last year, Jenny Liu and colleagues asked “Is it possible 
it? Is is worth it? Should we do it?” Ubydul Haque and 
colleagues’ Article in this issue addresses the “Is it worth 
it?” component from the point of view of donor funds to 
Bangladesh. Bangladesh is on the path towards national 
elimination, and malaria is now endemic in only 13 of 
64 districts. Haque and colleagues’ ﬁ ndings suggest that 
Bangladesh’s national malaria elimination programme is 
eﬃ  cient and cost-eﬀ ective and could provide an example 
to other countries embarking on elimination.
There is a lot to learn from the research in this issue: by 
examining the successes and failures of diﬀ erent national 
programmes, the inevitable spread of genetic diseases 
can be managed and the gradual cornering of some of the 
world’s major infectious diseases can be accelerated.
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